300+ investors in your industry, stage, and region Get
Any industry
Google
Biotech
Proptech
Climate
Artificial Intelligence
Impact
EdTech
Sustainability
Clean Energy
Retail
Finance
Digital Media
Local
Enterprise Software
Travel
Platforms
Social
Recruiting
Mobile Apps
InsurTech
Wine and Spirits
Theatre
Oil and Gas
Non Profit
Celebrity
Social Impact
Cryptocurrency
SaaS
Film
Venture Capital
Crowdfunding
Infrastructure
Restaurants
Sporting Goods
Fashion
LGBT
Photography
Payments
Renewable Energy
Organic Food
Email
Financial Services
Manufacturing
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Community
Hardware
Gaming
Media (Entertainment)
Publishing
Facebook
Blockchain
Beauty
Real Estate
Life Science
B2B
Web3
Big Data
Video Games
Education
Medical
Wellness
Medical Device
Art
Social Media
Android
Internet
Franchise
Music
Mobile
Legal
Construction
Automotive
Sports
eSports
Hospitality
Cannabis
Mobile Advertising
Biotechnology
FinTech
Consumer
Transportation
Food and Beverage
Social Network
Enterprise
Software
Any country
South Korea
Oceania
Asia
Brazil
Africa
Middle East
Europe
LATAM
Saudi Arabia
Singapore
Finland
Gibraltar
Greece
Norway
Israel
Tajikistan
Italy
Taiwan
Zimbabwe
Puerto Rico
Russian Federation
Sweden
San Marino
Togo
Tunisia
Zambia
Nigeria
Isle of Man
Mongolia
Pakistan
Lebanon
Liberia
Romania
Mexico
Oman
Cameroon
Colombia
Australia
India
New Zealand
China
Indonesia
Sri Lanka
Vietnam
Armenia
Austria
Barbados
Albania
Bangladesh
Belgium
Argentina
Bahrain
Costa Rica
Belize
Belarus
Chile
Switzerland
Czech Republic
Estonia
Algeria
Iceland
Honduras
Cambodia
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Slovenia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Japan
Seychelles
Germany
Canada
United Kingdom
Ireland
Cyprus
Qatar
Spain
South Africa
United Arab Emirates
Azerbaijan
Bulgaria
Bolivia
Bermuda
Bahamas
Egypt
France
Georgia
Faroe Islands
Denmark
Dominican Republic
Ecuador
Croatia
Hong Kong
Ghana
Ethiopia
Grenada
Iraq
Hungary
Jordan
Jersey
Liechtenstein
Mali
Myanmar
Latvia
Morocco
Lithuania
Malaysia
Peru
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Thailand
El Salvador
Senegal
Tanzania
Uruguay
Ukraine
United States
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology Startup Investors in Austria (June 2026)

The most active venture capital funds and angel investors investing in Austria Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Austria Biotechnology startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
XISTA Science Ventures
VC Fund
12 Austria, France, Slovenia Seed, Pre-Seed, Series A Biotechnology, Medical, Software $511k–$20M
xista science ventures
VC Fund
9 Austria, Slovenia Seed, Pre-Seed, Series A Biotechnology, Medical, Software $511k–$20M
tecnet equity
VC Fund
7 Austria Seed, Series A Software, SaaS, Biotechnology $400k–$6M
SOSV
VC Fund
5 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
austria Wirtschaftsservice (aws)
VC Fund
5 Austria, Belgium Seed, Grant, Pre-Seed Software, Information Technology, SaaS $44k–$2.2M
MIG Capital
VC Fund
4 Germany, France, Austria Series A, Series B Biotechnology, Health Care, Therapeutics $1.6M–$54M
aws Gründungsfonds
VC Fund
3 Austria, Germany, United States Seed, Series A Software, SaaS, Information Technology $1.1M–$12M
Schnidar Harald
Angel
3 Austria Seed, Angel, Pre-Seed mHealth, Software, Biopharma
Gamma Capital Partners
VC Fund
2 Austria, United States, Germany Series A, Seed Software, Manufacturing, Information Technology $406k–$8M
Aescap Venture
VC Fund
2 United Kingdom, Austria, Belgium Series A, Series B Biotechnology, Pharmaceutical, Chemical $1.5M–$33M
Lansdowne Partners
VC Fund
2 United Kingdom, Austria, United States Series A, Series B Biotechnology, Finance, Genetics $6.8M–$100M
APEX Ventures
VC Fund
2 Germany, United Kingdom, Austria Seed, Series A, Pre-Seed Artificial Intelligence, Software, Health Care $511k–$28M
red-stars.com
VC Fund
2 Austria, Germany Seed, Series A Software, Biotechnology, Telecommunications $1.6M–$4.4M
Arax Capital Partners
VC Fund
2 Austria Seed Biotechnology, Health Care, Medical
eQventure
VC Fund
2 Austria, Switzerland Seed, Series A Software, Information Technology, Artificial Intelligence $549k–$6.6M
PUSH VC
VC Fund
2 Austria, Germany, United States Seed, Series A Software, Apps, Health Care $650k–$32M
BackBone Ventures
VC Fund
2 Switzerland, Germany, Israel Pre-Seed, Seed, Series A Artificial Intelligence, Information Technology, Software $583k–$105M
Nina Capital
VC Fund
2 United States, United Kingdom, Germany Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Software $573k–$22M
TSVC
VC Fund
2 United States, China, Canada Seed, Series A Software, Artificial Intelligence, Health Care $500k–$27M
Übermorgen Ventures
VC Fund
2 Germany, Switzerland, Finland Seed, Pre-Seed, Series A Software, Energy, Renewable Energy $344k–$12M
bmp Ventures
VC Fund
2 Germany, United States, Austria Seed, Series A Software, Information Technology, Manufacturing $30k–$5.9M
R42 Group
VC Fund
2 United Kingdom, United States, Austria Seed, Pre-Seed Biotechnology, Health Care, Software $439k–$4M
The Austrian Research Promotion Agency (FFG)
VC Fund
2 Austria, United States, Belgium Grant, Seed, Pre-Seed Software, Artificial Intelligence, Medical $67k–$3.5M
10x Founders
VC Fund
2 Germany, United States, Switzerland Seed, Series A, Pre-Seed Software, Information Technology, Artificial Intelligence $1.1M–$60M
Longevitytech.fund
VC Fund
2 United States, United Kingdom, The Netherlands Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Life Science $439k–$10M
FPS-Holding
VC Fund
2 Austria Seed Biotechnology, Health Diagnostics $420k–$429k
VP Venture Partners
VC Fund
2 Austria, Switzerland Seed Medical, Health Diagnostics, Internet $3M–$3.3M
Venture Partners AG
VC Fund
1 Austria, United States Seed, Series B Internet, Software, Biotechnology
Hadean Ventures
VC Fund
1 Norway, Sweden, Germany Series A, Series B Biotechnology, Health Care, Medical $4.3M–$79M
Axilium Holding
VC Fund
1 Austria Seed Life Science, Biotechnology, Semiconductor
Fund F
VC Fund
1 Austria, United Kingdom Pre-Seed, Seed AgTech, EdTech, Software
Lansdowne Investment Company Cyprus
VC Fund
1 Austria Seed Life Science, Biotechnology, Semiconductor
Boehringer Ingelheim Venture Fund
VC Fund
1 United States, Germany, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $1.3M–$50M
EMBL Ventures
VC Fund
1 Germany, Austria, Ireland Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $3.9M–$70M
Novartis Venture Fund
VC Fund
1 United States, Switzerland, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $4.7M–$105M
42CAP
VC Fund
1 Germany, France, Sweden Seed, Series A, Pre-Seed Software, Artificial Intelligence, SaaS $1.3M–$19M
ReGen Ventures
VC Fund
1 United States, Austria, United Kingdom Seed, Series A, Series B Agriculture, Biotechnology, Farming
Andera Partners
VC Fund
1 France, United States, Germany Series B, Private Equity Biotechnology, Health Care, Medical $14M–$247M
Air Street Capital
VC Fund
1 United States, United Kingdom, France Seed, Series A, Series B Artificial Intelligence, Software, Biotechnology $2.9M–$300M
Synthesis Capital
VC Fund
1 United States, Israel, Austria Seed, Series A Biotechnology, Food and Beverage, Organic Food
HBM Partners
VC Fund
1 United States, Germany, Switzerland Series B, Series C Biotechnology, Medical, Health Care $2.5M–$125M
Sofinnova Partners
VC Fund
1 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $6M–$102M
GLS Ventures
VC Fund
1 Austria Series B Medical, Health Care, Biotechnology
INVEST AG
VC Fund
1 Austria, United States Seed, Private Equity Security, Hospitality, Food and Beverage
Pace Ventures
VC Fund
1 United States, Germany, Austria Seed, Pre-Seed Software, Biotechnology, Information Technology
Clima Now
VC Fund
1 Switzerland, Germany, Austria Seed, Grant, Pre-Seed Farming, Renewable Energy, Solar
SFG Steirische Wirtschaftsförderungsgesellschaft m.b.H
VC Fund
1 Austria Seed, Grant Software, Audio, Travel
Matthias Wilrich
Angel
1 Germany, Austria, Malaysia Seed, Pre-Seed, Series A E-Commerce, Delivery Service, Mobile Apps
Santo Holding
VC Fund
1 Germany, Austria Series B, Series C Biotechnology, Energy, Medical
ICL Planet Startup Hub
VC Fund
1 Israel, Austria Seed Biotechnology, Agriculture, Organic Food
Access all 140 investors in Austria Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

XISTA Science Ventures
VC Fund · Klosterneuburg, Niederosterreich, Austria · 12 investments in Austria Biotechnology startups

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Austria, France, Slovenia

Investor stats

  • Total investments: 30
  • Round size: Seed $576k–$7.8M; Pre-Seed $511k–$1.4M; Series A $5.2M–$20M
  • Lead/follow: 63% lead, 37% follow

Portfolio highlights

  • nista.io — gnista.io is a no code data clearing tool for energy managers.
  • contextflow — contextflow revolutionizes the medical information search process with the help of deep learning: our 3D image-based search engine for radiologists looks for regions of interest within images (currently 18+ patterns in lung CTs); when a suspicious pattern is detected, we immediately find visually similar cases, descriptions and relevant referenceinformation, affording doctors easy access to knowledge currently hidden in large medical image data and their associated reports...all within seconds. No more paging through books, guessing the right keyword or consulting various text-based reference search engines. In addition, our software can be configured to allow for prioritization of cases where patterns of interest are detected.contextflow is a spin-off of the Medical University of Vienna (MUW), Technical University of Vienna (TU) and European research project KHRESMOI. Founded by a team of AI and engineering experts in July 2016, the company was awarded the distinction of Most Promising Startup by the BCS Search Industry, received the Digital Innovation Award by the Austrian Federal Ministry of Education, Science and Research and was selected as one of 19 startups out of over 700 applications to participate in the Philips HealthWorks accelerator program. It is currently testing its 3D image-based software with six partners, expanding internationally to other locations later this year.
  • G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
Show all investments...

xista science ventures
VC Fund · Klosterneuburg, Niederosterreich, Austria · 9 investments in Austria Biotechnology startups

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Austria, Slovenia

Investor stats

  • Total investments: 22
  • Round size: Seed $1.8M–$7.8M; Pre-Seed $511k–$1.4M; Series A $5.2M–$20M
  • Lead/follow: 64% lead, 36% follow

Portfolio highlights

  • subdron — subdron turns the seabed from a blind spot into a monitored domain.
  • infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
  • VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Show all investments...

tecnet equity
VC Fund · Sankt Polten, Niederosterreich, Austria · 7 investments in Austria Biotechnology startups

tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.

Show more...

Investment focus

  • Industry: Software, SaaS, Biotechnology
  • Stage:Seed, Series A
  • Geography: Austria

Investor stats

  • Total investments: 60
  • Round size: Seed $400k–$2.5M; Series A $583k–$6M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2009

Portfolio highlights

  • Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
  • Orderlion — Streamline your wholesale business with Orderlion's ordering app. Automate orders, boost sales, and enhance customer loyalty. Find out more!
  • VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 5 investments in Austria Biotechnology startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

austria Wirtschaftsservice (aws)
VC Fund · Vienna, Wien, Austria · 5 investments in Austria Biotechnology startups

The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Seed, Grant, Pre-Seed
  • Geography: Austria, Belgium

Investor stats

  • Total investments: 56
  • Round size: Seed $439k–$2.2M; Grant $64k–$603k; Pre-Seed $44k–$1.9M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • Repentium — Repentium serves industrial manufacturers seeking reproducible, cost-efficient 3D printing and engineering-grade plastic parts.
  • Another Earth — Another Earth is building an AI-powered simulation and synthetic data platform for Earth Observation. As our planet changes, AI models need scalable, high-quality training data to keep pace. Another Earth provides synthetic data, scenario simulations and predictions required to accelerate AI development, and enable faster, smarterdecision-making—enabling smarter decisions for a more resilient world.
  • Cycuria Therapeutics — While new therapies, such as FLT3 inhibitors and venetoclax-based regimens, have improved initial response rates, durable remissions and long-term survival
Show all investments...

MIG Capital
VC Fund · München, Bayern, Germany · 4 investments in Austria Biotechnology startups

MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B
  • Geography: Germany, France, Austria

Investor stats

  • Total investments: 93
  • Round size: Series A $2.2M–$28M; Series B $1.6M–$54M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: May invest from a new fund soon — raised $70M in 2014

Portfolio highlights

  • AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
  • Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
  • ASTRA Therapeutics — Astra - Therapeutics
Show all investments...

aws Gründungsfonds
VC Fund · Vienna, Wien, Austria · 3 investments in Austria Biotechnology startups

aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Seed, Series A
  • Geography: Austria, Germany, United States

Investor stats

  • Total investments: 83
  • Round size: Seed $1.1M–$5.2M; Series A $1.1M–$12M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Upnano — Upnano engages in the manufacture and commercialization of 3D printing systems.
  • OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
  • HelloBello — HelloBello offers freshly cooked and cooled delivered human-grade food tailored to each dog’s nutritional needs. HelloBello is a PetTech company with a strong focus on the German speaking markets (for now). HelloBello’s personalized meals are free of any by-products and are portioned, packaged, and delivered directly to your door. By working with aspecialized veterinarian, HelloBello is able to derive each dog’s exact nutritional needs based on a proprietary algorithm. The recipes are made of natural sources like millet and seaweed, instead of heavy use of supplements, which makes it easier for the dog to absorb and get true nutritional benefits.Our credo in German is " ... Frisch. Individuell. Geliefert. - Frischfutter ist einfach besser ..."
Show all investments...

Schnidar Harald
Angel · Vienna, Wien, Austria · 3 investments in Austria Biotechnology startups

Entrepreneur, Angel Investor, Scientist and Inventor

Show more...

Investment focus

  • Industry: mHealth, Software, Biopharma
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Austria

Investor stats

  • Total investments: 7
  • Lead/follow: 86% lead, 14% follow

Portfolio highlights

  • SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
Show all investments...

Gamma Capital Partners
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotechnology startups

gcp gamma capital partners is an independent Venture Capital investment firm, focused on financing dynamic technology companies in Austria, Germany, Switzerland and CEE countries.They seek to achieve superior returns by finding assets with substantial potential in their regional and sectoral focus areas, before they appear on the radar screenof mainstream players in terms of stage and/or initial investment size.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Series A, Seed
  • Geography: Austria, United States, Germany

Investor stats

  • Total investments: 29
  • Round size: Seed $406k–$636k; Series A $1.3M–$8M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Icomasoft — Icomasoft ag is a Swiss pioneer of agent-less software solutions providing unprecedented transparency across your virtual and physical IT infrastructure in heterogeneous datacenters.IcomasoftÂ:registered: software solutions collect essential information for mission-critical and business-critical decisions and provide simplified, automated tasksthat support administrators, IT managers and Executives to easily and confidently analyze, plan and optimize their IT capacity. icomasoftÂ:registered: software solutions are vital for your datacenter clarity.
  • Henn GmbH & Co KG — Henn GmbH & Co KG develops and commercializes rapid connecting systems for hoses in automotive engine blocks.
  • CNSystems Medizintechnik — CNSystems Medizintechnik sells, manufactures, and develops equipment for non-invasive, continuous monitoring of blood pressure and other essential vital parameters. The company was founded in May 1998 as a spin-off from the Medical University and University of Technology Graz, Austria.
Show all investments...

Aescap Venture
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 2 investments in Austria Biotechnology startups

Aescap Venture is an Amsterdam-based investment company that pursues investments in biotech companies in Europe and the U.S.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Chemical
  • Stage:Series A, Series B
  • Geography: United Kingdom, Austria, Belgium

Investor stats

  • Total investments: 18
  • Round size: Series A $1.5M–$20M; Series B $5.2M–$33M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Biocartis — Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. We provide next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus on oncology.
  • Vivendy Therapeutics — Vivendy Therapeutics Ltd. has developed a specific recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) that is specifically modified to improve enzyme activity - enhancing the efficacy of the therapy in MPS IVA significantly
  • Affectis Pharmaceuticals — Affectis is a pharmaceuticals company developing novel drugs for the treatment of neurodegenerative and neuroinflammatory diseases.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Lansdowne Partners
VC Fund · London, England, United Kingdom · 2 investments in Austria Biotechnology startups

Fundamental Equity Investing, since 1998

Show more...

Investment focus

  • Industry: Biotechnology, Finance, Genetics
  • Stage:Series A, Series B
  • Geography: United Kingdom, Austria, United States

Investor stats

  • Total investments: 43
  • Round size: Series A $6.8M–$55M; Series B $8.5M–$100M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Nattergal — Nattergal is a company with a mission to deliver nature recovery at scale, to provide vital benefits for society and sustainable financial returns.
  • G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
  • amnis — Check out your possibilities to transfer money abroad, collect international payments and exchange currencies all in one account. Make payments fast with amnis.
Show all investments...

APEX Ventures
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotechnology startups

APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United Kingdom, Austria

Investor stats

  • Total investments: 57
  • Round size: Seed $1.3M–$8M; Pre-Seed $511k–$3M; Series A $5.2M–$28M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
  • Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
  • OroraTech — From safeguarding forests and ecosystems to protecting communities and critical assets, OroraTech's advanced technology and reliable insights address challenges, mitigate risks, and drive meaningful impact.
Show all investments...

red-stars.com
VC Fund · 2 investments in Austria Biotechnology startups

We back B2B software and life-sciences companies with limitless scalability.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Telecommunications
  • Stage:Seed, Series A
  • Geography: Austria, Germany

Investor stats

  • Total investments: 8
  • Round size: Seed $1.6M–$4.4M
  • Lead/follow: 75% lead, 25% follow

Portfolio highlights

  • Txture — End-To-End Cloud Transformation Platform
  • HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
  • MAVOCO — We create a carrier-grade software for IoT champions, trusted by tier-1 Mobile network operators.
Show all investments...

Arax Capital Partners
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotechnology startups

ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 5
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
  • Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
  • Calyxha Biotechnologies GmbH — A new perspective on inflammation
Show all investments...

eQventure
VC Fund · Graz, Steiermark, Austria · 2 investments in Austria Biotechnology startups

Entrepreneurs for Entrepreneurs

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: Austria, Switzerland

Investor stats

  • Total investments: 57
  • Round size: Seed $549k–$1.2M; Series A $768k–$6.6M
  • Lead/follow: 79% lead, 21% follow

Portfolio highlights

  • Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
  • Respory — Respory provides real-time people-tracking using proprietary radar sensors, all without capturing personal data. Our scalable sensor network, powered by AI-driven algorithms, delivers precise customer journey insights, critical for in-store performance in retail.
  • 2nd Cycle — 2nd Cycle creating a cost-effective, fully automated, and scalable solution for modules for a second life cycle.
Show all investments...

PUSH VC
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotechnology startups

| Investments that move industries

Show more...

Investment focus

  • Industry: Software, Apps, Health Care
  • Stage:Seed, Series A
  • Geography: Austria, Germany, United States

Investor stats

  • Total investments: 35
  • Round size: Seed $650k–$8.1M; Series A $5M–$32M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Emmi AI — Emmi AI thinks that the nexus of physics and artificial intelligence represents the next frontier in industrial engineering. The world of large-scale engineering and manufacturing is ripe for transformation, yet today's innovation processes are hindered by slow, costly simulations and prohibitive computational requirements.
  • Voltrac — Voltrac is a robotics company that develops an autonomous, fully electric tractor platform called THOR, designed to operate in demanding environments for both agricultural and logistics use. THOR employs per-wheel electric motors instead of a conventional drivetrain, reducing mechanical complexity and maintenance requirements. It runs on swappable200 kWh battery packs, enabling long-duration operations and continuous work cycles. The platform supports a standard three-point hitch (Category II) and can be configured with a flatbed, making it versatile for fieldwork or transport tasks. Voltrac’s autonomy system combines reinforcement learning with real-time sensor data to adapt driving behavior and implements to changing terrain and crop conditions. Beyond farming, THOR is also intended for frontline logistics missions, with modular designs that can support cargo transport and resilience in challenging settings.
  • Circonomit — Building the world's environmental data infrastructure - We are the sustainability counterpart to what Excel, Sheets and Datev are to financial planning and accounting. Our mission is to create the first decision intelligence platform to bridge sustainability and finance by building the global standard for the collection and aggregation ofcorporate environmental data.
Show all investments...

BackBone Ventures
VC Fund · Zurich, Zurich, Switzerland · 2 investments in Austria Biotechnology startups

BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Switzerland, Germany, Israel

Investor stats

  • Total investments: 69
  • Round size: Seed $966k–$5M; Pre-Seed $583k–$2.1M; Series A $5M–$105M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Neon — With neon, you can pay, save and manage your money. Digitally, securely and with no hidden fees. Open your account online in less than 10 minutes!
  • Evoralis — Evoralis is an enzyme development company that specializes in the discovery and development of plastic-depolymerizing enzymes. It is a spin-out from the University of Cambridge.
  • Proofcheck — Proofcheck is a multilingual AI proofreading platform and a collaborative in-browser workspace for PDFs and epubs. Their next-generation AI workflow and collaboration tool helps content creators quickly catch costly mistakes before they reach audiences. Proofcheck is headquartered in Vienna, Wien and was founded in 2022.
Show all investments...

Nina Capital
VC Fund · Barcelona, Catalonia, Spain · 2 investments in Austria Biotechnology startups, 6 in the past 12 months

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 81
  • Round size: Seed $2M–$5.2M; Pre-Seed $573k–$2.4M; Series A $5M–$22M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
  • io Health — Io Health Technologies LLC provides AI-driven tools for home health documentation and workflow automation in healthcare.
  • Sober Sidekick — Gamified peer to peer support
Show all investments...

TSVC
VC Fund · Los Altos, California, United States · 2 investments in Austria Biotechnology startups

Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 234
  • Round size: Seed $500k–$7M; Series A $2M–$27M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Dexmate — Dexmate is a robotics startup focused on developing general-purpose mobile robots. The company specializes in robots with manipulation capabilities. Their technology aims to enhance automation across various industries.
  • EGI Battery — EGI Battery manufactures batteries for autonomous systems, aviation, robotics, and mobility.
  • Petal Surgical — Petal is a surgical technology company pioneering incisionless surgery through Acoustic Sculpting, a proprietary form of boiling histotripsy. Our platform uses focused sound waves to precisely destroy harmful tissue without cuts, heat, or toxicity offering gentler alternative to traditional surgery.
Show all investments...

Übermorgen Ventures
VC Fund · Zürich, Zurich, Switzerland · 2 investments in Austria Biotechnology startups

We are an early stage VC for climate tech startups.

Show more...

Investment focus

  • Industry: Software, Energy, Renewable Energy
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Germany, Switzerland, Finland

Investor stats

  • Total investments: 48
  • Round size: Seed $2.2M–$6.2M; Pre-Seed $344k–$4.2M; Series A $2.7M–$12M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Ecair — Ecair provides software for indoor air quality and energy management. The platform aggregates data from connected sensors to track pollutants, CO2, humidity, temperature, and particulate matter in real time. Dashboards, alerts, and APIs support building operations, facility managers, and ESG teams. Algorithms estimate exposure, flag ventilationissues, and suggest HVAC adjustments to balance comfort, health, and energy use. Reporting tools support certifications and compliance, and data exports integrate with BMS, CMMS, and data warehouses. Services include device provisioning, calibration management, and analytics consulting for multi-site portfolios.
  • Carbo Culture — We are a project developer with proprietary climate technology. We are building a rapidly scalable biochar carbon removal solution.
  • Milvus Advanced — Our Midas-touch alloys replicate the functional properties of platinum-group metals at a fraction of the cost.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
bmp Ventures
VC Fund · Berlin, Berlin, Germany · 2 investments in Austria Biotechnology startups, 7 in the past 12 months

bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.

Show more...

Investment focus

  • Industry: Software, Information Technology, Manufacturing
  • Stage:Seed, Series A
  • Geography: Germany, United States, Austria

Investor stats

  • Total investments: 118
  • Round size: Seed $151k–$3.4M; Series A $30k–$5.9M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
  • Solar Materials — SOLAR MATERIALS developed a recycling technology for solar modules, which recovers all raw materials for a circular solar industry.
  • Litherm Technologies — Litherm Technologies GmbH is a German deep‑tech startup focused on decarbonizing lime and cement production using fully electric kiln technology.
Show all investments...

R42 Group
VC Fund · Stanford, California, United States · 2 investments in Austria Biotechnology startups

R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, United States, Austria

Investor stats

  • Total investments: 27
  • Round size: Seed $654k–$4M; Pre-Seed $439k–$2M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
  • xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
  • Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
Show all investments...

The Austrian Research Promotion Agency (FFG)
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotechnology startups

The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.The FFG was foundedon 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Medical
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Austria, United States, Belgium

Investor stats

  • Total investments: 69
  • Round size: Seed $300k–$2.2M; Grant $67k–$3.5M; Pre-Seed $480k–$1.9M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • Chatlyn — Automated, AI-enhancend guest engagement, where your clients are most comfortable.
  • OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
  • Another Earth — Another Earth is building an AI-powered simulation and synthetic data platform for Earth Observation. As our planet changes, AI models need scalable, high-quality training data to keep pace. Another Earth provides synthetic data, scenario simulations and predictions required to accelerate AI development, and enable faster, smarterdecision-making—enabling smarter decisions for a more resilient world.
Show all investments...

10x Founders
VC Fund · Munich, Bayern, Germany · 2 investments in Austria Biotechnology startups

Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United States, Switzerland

Investor stats

  • Total investments: 86
  • Round size: Seed $2.7M–$12M; Pre-Seed $1.1M–$12M; Series A $6.9M–$60M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Raus — Raus is a hospitality-tech startup that offers new opportunities to take a break from big city life. Raus serves as a welcome escape from the seemingly endless demands and constant stimuli of modern life with perfectly simple cabins, close enough for a spontaneous getaway, far enough away to completely unwind.
  • Cylib — The cylib process transfers waste from end of life batteries or production scrap into marketable products. Cylib covers all steps from the discharging of batteries up to hydrometallurgical extraction. Since the whole process is in one hand, also the processing of production scraps as well as black mass is possible.
  • Penny — Find all your old pensions, automatically. UK Fintech Awards Pension-tech of the year.
Show all investments...

Longevitytech.fund
VC Fund · Prague, Hlavni mesto Praha, Czech Republic · 2 investments in Austria Biotechnology startups

Investing globally in technologies extending healthy lifespans

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 48
  • Round size: Seed $1.7M–$10M; Pre-Seed $439k–$3.2M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Klothea Bio — Klothea Bio is a protein well known for its powerful anti-aging capabilities, such as tumor suppression, neuroprotection, and antioxidative actions. As people age, their klotho levels drop to harmful levels. The metabolic disease syndrome will be the focus of the first investigations, while later studies will try to extend therapeutic applicationsto cancer, Alzheimer's disease, obesity, and other age-related diseases.
  • Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
  • MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
Show all investments...

FPS-Holding
VC Fund · 2 investments in Austria Biotechnology startups

Investment focus

  • Industry: Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 2
  • Round size: Seed $420k–$429k
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Sola Diagnostics — Product: Sola Diagnostics’ WID®-easy test is a non-invasive epigenetic solution for detecting endometrial cancer in women with abnormal uterine bleeding. By analyzing DNA methylation markers from a simple vaginal swab, it offers high accuracy, reducing false positives and unnecessary surgeries. Target Audience: Designed for gynecologists andhealthcare providers, WID®-easy streamlines diagnostics, cutting costs and false alarms. Women benefit from a painless, accessible test that ensures earlier and more precise detection. Technology: Powered by advanced DNA methylation research, WID®-easy identifies cancer-specific epigenetic markers. With PCR-based analysis and robust clinical validation, it delivers fast, reliable results that integrate seamlessly into medical workflows. Market Positioning: WID®-easy fills a critical gap as a first-line diagnostic for abnormal uterine bleeding. Its clinical validation, accuracy, and cost-efficiency set it apart from invasive procedures. Its ease of use and scalability position it for widespread adoption. Milestones: Sola Diagnostics launched in Austria and Switzerland in 2024 and expanded to Great Britain in 2025. UKCA Marking was registered in December 2024. So far, private equity investments totaling €2.4M have supported Sola's mission to revolutionize women’s health diagnostics.
Show all investments...

VP Venture Partners
VC Fund · Zürich, Zurich, Switzerland · 2 investments in Austria Biotechnology startups

VP Venture Partners is a venture capital firm invests in healthcare companies.

Show more...

Investment focus

  • Industry: Medical, Health Diagnostics, Internet
  • Stage:Seed
  • Geography: Austria, Switzerland

Investor stats

  • Total investments: 3
  • Round size: Seed $3M–$3.3M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
  • Moonlight AI — Moonlight AI empowers pathologists and hematologists to make therapeutic decisions backed by genomic insight. Moonlight AI was founded in 2022 and is headquartered in Jura, Switzerland.
  • aTension.life — aTension.life is a company focused on advancing the diagnosis and treatment of hypertension through precision medicine. It employs cutting-edge mass spectrometry technology to identify the underlying causes of uncontrolled hypertension using a single blood sample. aTension.life aims to provide personalized diagnostic solutions that enhance patientcare and support laboratories with accurate and reliable tools. The company's mission is to improve the quality of life for hypertensive patients by making advanced diagnostics widely accessible and enabling more effective, individualized therapies.
Show all investments...

Venture Partners AG
VC Fund · Zürich, Zurich, Switzerland · 1 investments in Austria Biotechnology startups

Venture Partners AG is a leading European Venture firm with locations in Switzerland and Boston.

Show more...

Investment focus

  • Industry: Internet, Software, Biotechnology
  • Stage:Seed, Series B
  • Geography: Austria, United States

Investor stats

  • Total investments: 2
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Allcyte — At Exscientia, we combine the power of AI and human creativity to make safer and more sophisticated drugs available to all. Visit our website to find out more.
  • apps4biz.com — At apps4biz.com™, ease-of-use and affordability are Their passion. They understand that a small business does not have the resources to learn, implement and fully utilize complex systems. apps4biz.com solutions enable you to quickly take advantage of your investment. And, you can easily tailor the apps4biz.com solution to accommodate your businessnow, and as your company grows.
Show all investments...

Hadean Ventures
VC Fund · Oslo, Oslo, Norway · 1 investments in Austria Biotechnology startups

Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: Norway, Sweden, Germany

Investor stats

  • Total investments: 27
  • Round size: Series A $4.3M–$79M; Series B $28M–$68M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely still investing — raised $105M in 2021

Portfolio highlights

  • Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
  • Emergence Therapeutics — Emergence Therapeutics is a European biopharmaceutical company developing novel antibody-drug conjugates (ADC) to treat high-need cancers. Its lead program combines a highly specific antibody with optimized linker and payload technology to target Nectin-4 – an important target for a broad range of cancers which has been clinically validated as anADC target by enfortumab vedotin, now approved for the treatment of urothelial cancers by the US Food and Drug Administration. Emergence is also actively exploring opportunities to develop further first- or best-in-class ADCs driven by therapeutic need.
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

Axilium Holding
VC Fund · 1 investments in Austria Biotechnology startups

Axilium Holding

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Semiconductor
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Fund F
VC Fund · 1 investments in Austria Biotechnology startups

The European Venture Fund that backs gender-diverse founder teams.

Show more...

Investment focus

  • Industry: AgTech, EdTech, Software
  • Stage:Pre-Seed, Seed
  • Geography: Austria, United Kingdom

Investor stats

  • Total investments: 8
  • Lead/follow: no public data

Portfolio highlights

  • Circonomit — Building the world's environmental data infrastructure - We are the sustainability counterpart to what Excel, Sheets and Datev are to financial planning and accounting. Our mission is to create the first decision intelligence platform to bridge sustainability and finance by building the global standard for the collection and aggregation ofcorporate environmental data.
  • KOA Biotech — Detecta enfermedades a tiempo y maximiza tus resultados.
  • Willow Stories — Preserve your legacy and honor loved ones by creating lasting memorials.
Show all investments...

Lansdowne Investment Company Cyprus
VC Fund · 1 investments in Austria Biotechnology startups

Lansdowne Investment Company Cyprus

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Semiconductor
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
Show all investments...

Boehringer Ingelheim Venture Fund
VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 1 investments in Austria Biotechnology startups

Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 94
  • Round size: Seed $1.3M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: May invest from a new fund soon — raised $250M in 2018

Portfolio highlights

  • Perfood — Perfood is a digital therapeutic startup that identifies what actions need to take on a personalized level, to prevent or fight diseases. Using sensors, lab results, and holistic analyses, they derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. They call this approach digitaltherapeutics. A digital solution that is just as effective as a drug. But without side effects.
  • Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
  • Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.
Show all investments...

EMBL Ventures
VC Fund · Heidelberg, Baden-Wurttemberg, Germany · 1 investments in Austria Biotechnology startups

EMBL Ventures invest throughout Europe with the aim to build companies that create significant commercial opportunities based on new therapeutic treatment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: Germany, Austria, Ireland

Investor stats

  • Total investments: 11
  • Round size: Series A $3.9M–$15M; Series B $20M–$70M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Arsanis — Arsanis is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. A deep understanding of the pathogenesis of infection, paired with access to some of the most advanced mAb discovery techniques and platforms available today, has positioned Arsanis to build andadvance a pipeline of novel mAbs with multiple mechanisms of action and high potency against their intended targets.The company’s lead clinical program, ASN100, is aimed at serious Staphylococcus aureus infections and is being evaluated in Phase 2 clinical trial for the prevention of S. aureus pneumonia in high-risk, mechanically ventilated patients. In addition to ASN100, its preclinical pipeline is comprised of mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus.Arsanis is a U.S. company headquartered in Waltham, Massachusetts, with European research and preclinical development operations headquartered in Vienna, Austria (Arsanis Biosciences GmbH).
  • Topas Therapeutics — Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet need, including autoimmune diseases, allergies and anti-drug antibodies. The Topas Particle Conjugates technology platform induces antigen-specific immune tolerance by harnessing the liver’s naturalimmunology capabilities. The Company has several proprietary programs; lead product candidate TPM203 has recently entered clinical testing for pemphigus vulgaris, an orphan disease. Other programs are in anti-drug antibodies, celiac disease, Type 1 diabetes, as well as a multiple sclerosis program that is available for partnering.Topas has a research and option agreement with Eli Lilly and Company focused on antigen-specific tolerance induction and a multi-year agreement with Boehringer Ingelheim to collaborate in the field of anti-drug antibodies.Topas’ investors include: Epidarex Capital, Gimv, EMBL Ventures, Evotec and Boehringer Ingelheim Venture Fund.
  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Show all investments...

Novartis Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 1 investments in Austria Biotechnology startups

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 209
  • Round size: Series A $4.7M–$81M; Series B $11M–$105M; Series C $9M–$75M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2009

Portfolio highlights

  • Rhygaze — Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.
  • Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
  • Amphista Therapeutics — We are purposefully designing the next generation of targeted protein degraders to transform the lives of patients with intractable diseases.
Show all investments...

42CAP
VC Fund · Munich, Bayern, Germany · 1 investments in Austria Biotechnology startups

We are peers amongst entrepreneurs helping the brave to build game-changing companies, just like we have done ourselves.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, France, Sweden

Investor stats

  • Total investments: 94
  • Round size: Seed $2.2M–$6M; Pre-Seed $1.3M–$2.3M; Series A $2.3M–$19M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • Teemyco — Improve Engagement, Collaboration & Overall Happiness of Your Fully Online or Hybrid Team! Easy To Set Up & Integrates With Your Favorite Tools. 100% Free For Teams Up To 25 Users!
  • Nostos Genomics — Our genetic variant interpretation platform enables genetic testing labs to give more people with genetic diseases a clear and fast diagnosis.
  • Customs4trade (C4T) — Customs4trade simplifies Global Customs Management and Trade Compliance with a user-friendly software solution, CAS, which offers end-to-end automation.
Show all investments...

ReGen Ventures
VC Fund · Byron Bay, New South Wales, Australia · 1 investments in Austria Biotechnology startups

Investing in the ReGeneration

Show more...

Investment focus

  • Industry: Agriculture, Biotechnology, Farming
  • Stage:Seed, Series A, Series B
  • Geography: United States, Austria, United Kingdom

Investor stats

  • Total investments: 19
  • Lead/follow: no public data

Portfolio highlights

  • Anthrogen — Anthrogen is a Biotechnology Research firm using bacteria and enzymes for reducing carbon in the air by transforming it into chemicals.
  • Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
  • Differential Bio — Differential Bio is integrating scale-down experiments with AI-based modeling to optimize how industry-relevant microbes grow ("biomass fermentation") and produce ("precision fermentation"). By optimizing bioprocesses and growth conditions, the company is not only increasing their clients' R&D efficiency but alsodramatically improving bioproduction outcomes such as yield, cost efficiency, and product quality.
Show all investments...

Andera Partners
VC Fund · Paris, Ile-de-France, France · 1 investments in Austria Biotechnology startups

Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Private Equity
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 177
  • Round size: Series B $14M–$85M; Private Equity $110M–$247M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — raised $466M in 2022

Portfolio highlights

  • MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
  • Amolyt Pharma — AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
  • ImCheck Therapeutics — ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.
Show all investments...

Air Street Capital
VC Fund · London, England, United Kingdom · 1 investments in Austria Biotechnology startups

Air Street Capital provides venture capital funding and strategic support focused on early-stage companies that develop products based on artificial intelligence. It invests primarily at pre-seed, seed, and Series A stages in firms working on AI-first technology, software infrastructure, machine-learning tools, and AI-enabled life scienceapplications. The firm pairs capital investment with advisory input on product, market, and technology strategy, and facilitates connections to its broader network of AI and technology stakeholders. Air Street Capital also shares industry insights through publications and community initiatives aimed at supporting AI and related tech ecosystems.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 42
  • Round size: Seed $2.9M–$15M; Series A $5.7M–$33M; Series B $64M–$300M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • intenseye — Intenseye | Reduce workplace incidents and increase efficiency with the world's #1 safety management software.
  • Profluent Bio — Profluent Bio is an AI-first protein design company that designs novel, optimal proteins that bypass existing barriers in industry.
  • Interloom Technologies — Interloom is the first Navigation System for Work. It helps you map how your teams actually work. Grounded in this precedent, it guides your operational teams with suggested next steps and relevant context and empowers your AI agents to follow their lead.
Show all investments...

Synthesis Capital
VC Fund · London, England, United Kingdom · 1 investments in Austria Biotechnology startups

Synthesis Capital is an investment manager transforming our food system through food technology.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Organic Food
  • Stage:Seed, Series A
  • Geography: United States, Israel, Austria

Investor stats

  • Total investments: 9
  • Lead/follow: no public data

Portfolio highlights

  • Triplebar — Triplebar provides sustainability, biotechnology, and synthetic biology research.
  • Savor — Savor makes delightfully rich foods without animals, farmland, fertilizers, hormones, or antibiotics.
  • Hyfé — Hyfé Foods is a biotech company producing ingredients by leveraging fungal fermentation to upcycle water byproducts from food manufacturers.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
HBM Partners
VC Fund · Zug, Zug, Switzerland · 1 investments in Austria Biotechnology startups

HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series B, Series C
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 40
  • Round size: Series B $7.7M–$125M; Series C $2.5M–$113M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: May invest from a new fund soon — raised $105M in 2012

Portfolio highlights

  • Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
  • Neuron23 — Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
  • Mineralys Therapeutics — Evolving science is revealing the importance of aldosterone in cardio-renal-metabolic diseases.We are focused on improving outcomes for people managing hypertension, CKD and related diseases that are driven by dysregulated aldosterone. About Aldosterone
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 1 investments in Austria Biotechnology startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 298
  • Round size: Series A $6M–$65M; Series B $10M–$102M; Series C $11M–$100M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • protera — Protera is advancing the science of protein engineering to address some of the most critical problems and opportunities in food, agriculture, the environment and human health. We streamline protein design and development with MADI, our proprietary deep learning algorithm, to predict high value protein products and enzymes with unprecedented speed.Our in-house lab generates small quantities of the new predicted structures to validate their desired performance. Upon lab validation, we collaborate with our clients on next steps to move from pilot to industrial scale production.
  • Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
  • T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
Show all investments...

GLS Ventures
VC Fund · Sugar Land, Texas, United States · 1 investments in Austria Biotechnology startups

GLS Ventures

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series B
  • Geography: Austria

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Nabriva Therapeutics — MPOMM Adalah link resmi berlisensi agen mpo slot paling gacor hari ini dengan pilihan bermain di server slot anti rungkat terjamin kemenangan jackpot maxwin menang berapapun akan di bayar lunas
Show all investments...

INVEST AG
VC Fund · Linz, Oberosterreich, Austria · 1 investments in Austria Biotechnology startups

INVEST AG is the investment arm of the Raiffeisen bank group of Upper Austria and is one of Austria’s leading private equity funds, managing a volume of 180 million euros. As an evergreen fund with an indefinite term, we are able to provide long-term stability and a solid foundation for future success, which is particularly relevant for anincreasing number of medium-sized companies facing a growing need for equity.The benefits of private equity:No personal liability of the partners No securities to weigh you down Greater risk capacity Since its founding in 1994, INVEST AG has already invested equity and mezzanine capital in more than 140 companies in a wide variety of sectors. Currently, 26 companies in Austria and the south of Germany trust in our expertise and benefit from our support in operational, commercial, and strategic matters.Whatever situation you find yourself in as a company and whatever problem you are seeking a custom-made solution to, be assured that you will always find us to be a highly experienced and reliable partner.

Show more...

Investment focus

  • Industry: Security, Hospitality, Food and Beverage
  • Stage:Seed, Private Equity
  • Geography: Austria, United States

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • NEOH USA — NEOH USA is a fast growing new food brand from Kirkland, WA and the leader in Crossbars. It satisfies your sweet tooth without the guilt. Crossbars taste as great as a candy bars but are protein bars.
  • HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
  • RadarServices — RadarServices is the European market leader for proactive IT security monitoring and IT risk detection as managed services. The services uniquely combine automated detection of security relevant issues and risks with the analysis and assessment done by experts. Data never leaves the clients‘ premises.
Show all investments...

Pace Ventures
VC Fund · Berlin, Berlin, Germany · 1 investments in Austria Biotechnology startups

Investing at the intersection of climate and health.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: United States, Germany, Austria

Investor stats

  • Total investments: 13
  • Lead/follow: no public data

Portfolio highlights

  • Cellbyte — AI Agents for Pricing and Market Access Teams in the Pharmaceutical Industry.
  • Vema Hydrogen — Vema Hydrogen is a pioneering clean hydrogen production company. It helps to fight the enormous decarbonization issue.
  • ChemFinity Technologies — ChemFinity Technologies is a chemical company that offers critical metal recovery, water purification, and gas separation services.
Show all investments...

Clima Now
VC Fund · Zürich, Zurich, Switzerland · 1 investments in Austria Biotechnology startups

Wir wollen unser wichtigstes Erbe erhalten. Eine lebenswerte Erde.

Show more...

Investment focus

  • Industry: Farming, Renewable Energy, Solar
  • Stage:Seed, Grant, Pre-Seed
  • Geography: Switzerland, Germany, Austria

Investor stats

  • Total investments: 8
  • Lead/follow: no public data

Portfolio highlights

  • Planeteers — We capture CO2 in water and unleash the potential of the oceans as the largest carbon sink on our planet.
  • Infrascreen — The transparent aluminium screen for extra energy-savings in greenhouses. Thanks to it's low-e coating, it saves up to 20% more than a regular energy-saving screen
  • Kynda — Keen 4 Greens offers a wide range of vegan products. Founded in 2019, Keen 4 Greens is based in Hamburg, Germany.
Show all investments...

SFG Steirische Wirtschaftsförderungsgesellschaft m.b.H
VC Fund · Graz, Steiermark, Austria · 1 investments in Austria Biotechnology startups

Financing for startups in Styria

Show more...

Investment focus

  • Industry: Software, Audio, Travel
  • Stage:Seed, Grant
  • Geography: Austria

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • teamazing — Unlock your team's full potential! Tailored workshops, tools & events for continuous team development. Analyze, build, and grow with teamazing!
  • Busfinder.com — Reisebus mieten mit Fahrer. Bus Angebote von Busunternehmen vergleichen und online buchen. Jetzt Bus buchen auf busfinder.com
  • Delphi Data Labs — Unlock your hidden market potential and use your data to its fullest potential. We offer everything from market analysis, data modelling and vizualization to system integration in your existing technical environment to super-charge your decision-making.
Show all investments...

Matthias Wilrich
Angel · Berlin, Berlin, Germany · 1 investments in Austria Biotechnology startups

Matthias Wilrich is the VP Vehicles and Supply Chain at TIER Mobility.

Show more...

Investment focus

  • Industry: E-Commerce, Delivery Service, Mobile Apps
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Germany, Austria, Malaysia

Investor stats

  • Total investments: 10
  • Lead/follow: no public data

Portfolio highlights

  • Lumaly — Lumaly is a browser extension that automatically tries out and uses all available voucher codes in the cart when shopping online.
  • MAYD — MAYD provides telepharmacy platform providing healthcare-related goods in a convenient way by delivering it to doorstep.
  • HELLO INSIDE — HELLO INSIDE is a scientific self care company empowering people to have data-driven conversations with their bodies. Unlock your best self.
Show all investments...

Santo Holding
VC Fund · Zürich, Zurich, Switzerland · 1 investments in Austria Biotechnology startups

Santo Holding is a Zurich-based investment firm funding biotechnology, pharmaceutical, life sciences, and healthcare companies.

Show more...

Investment focus

  • Industry: Biotechnology, Energy, Medical
  • Stage:Series B, Series C
  • Geography: Germany, Austria

Investor stats

  • Total investments: 6
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
  • SuppreMol — SuppreMol is a privately held biotechnology company that pioneers a novel approach for the treatment of autoimmune diseases which could lead to the cure of these disorders instead of merely treating their symptoms.
  • Efficient Energy — Efficient Energy GmbH is an innovative manufacturer and system supplier of environmentally friendly refrigeration technology, based in Feldkirchen near Munich, Germany. The company developed the Bluezero-technology, which uses water as a refrigerant and and thereby entirely avoids fluorinated refrigerants (HFCs). Efficient Energy helps itscustomers overcome the increasing regulatory challenges of refrigeration technology, and offers them long-term, sustainable solutions with its eChiller model range. The eChiller chilled water units are ideally suited for process cooling, machine cooling and the cooling of technical equipment and data centres and provide cooling capacities from 35 kW to 120 kW, depending on the model. With its outstanding cost efficiency and low CO2 footprint, companies benefit on many fronts. The pioneering technology has also been noticed by politics and the media, and has received multiple awards for the eChiller. These include among others the European Business Award for the Environment 2018/2019 from the European Comission and the Red Herring Europe Top 100 in 2020.
Show all investments...

ICL Planet Startup Hub
VC Fund · 1 investments in Austria Biotechnology startups

ICL Startup Accelerator focuses on foodtech and crop nutrition startups, innovative products, and accelerates their market penetration

Show more...

Investment focus

  • Industry: Biotechnology, Agriculture, Organic Food
  • Stage:Seed
  • Geography: Israel, Austria

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Lavie bio — LaVie Bio develops bacterial compositions that are sprayed on plants, used to coat seeds, or are integrated in the soil around the plant in order to improve the crop or the plant's features.
  • Arkeon Biotechnologies — Arkeon converts CO2 into resources to power tomorrow's industries.
Show all investments...

Biotechnology Investor funding in Austria at a glance

Stats across 106 deals from 140 investors.

140
investors
in Austria Biotechnology startups
106
deals
in Austria Biotechnology startups
$5.5M
median round
in Austria Biotechnology startups
45%
lead investors
lead at least one round
32%
Seed
most common funding stage
99/1
VC / Angel
share of investor count

Access all 140 investors in Austria Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology Investors in Austria investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 140 investors investing in Austria Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists